SightfileU.S. market data from official filings

Companies › LXEO

LEXEO THERAPEUTICS INC (LXEO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001907108 · EDGAR filings · Updated 2026-07-01

LEXEO THERAPEUTICS INC (LXEO) has reported institutional ownership of 107.8%, with 138 institutional managers holding positions valued at $458.7M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
107.8%
Institutional managers
138
Reported 13F value
$458.7M
Insider activity
45 trans.
−$400.9K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LEXEO THERAPEUTICS INC has 138 institutional holders and institutional ownership of 107.8%.

Insider activity

Insiders reported 45 transactions (0 buys, 28 sells) across 7 reporting insiders, with a net reported value of −$400.9K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2023-12-11 (recurring since 2023-12-11) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BIOVENTUS (BVS) · AVALO THERAPEUTICS INC (AVTX) · CRESCENT BIOPHARMA INC. (CBIO) · INMODE LTD (INMD) · MIMEDX GROUP INC (MDXG) · ALLOGENE THERAPEUTICS INC (ALLO)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.